Comparative Analysis of Immunodeficiency in Patients with Monoclonal Gammopathy of Undetermined Significance and Patients with Untreated Multiple Myeloma
- 1 February 1989
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 29 (2), 217-228
- https://doi.org/10.1111/j.1365-3083.1989.tb01119.x
Abstract
The objectives of this study were firstly, to compare the immunophenotype of patients with monoclonal gammopathy of undetermined significance (MGUS) with that of patients with newly diagnosed, untreated multiple myeloma (Unt. MM). Our second objective was to determine which variables might distinguish patients with MGUS and early MM. The CD4/CD8 ratio in both patient groups differed significantly from normal as a result of a decrease in the proportion of CD4+ cells. Similarly, surface immunoglobulin-positive (Ig+) B cells were significantly reduced in both groups. Also, some impairment of Ig secretion was observed. An in vitro specificity study of B cells showed an enriched proportion of B cells specific for tetanus toxoid (which may be indicative of enrichment for memory B cells) in both MGUS and Unt. MM patients. Further to this, in MM patients but not in MGUS patients, there was an enriched proportion of B cells specific for determinants on the F(ab'')2 fragment of Ig. This suggests an anomalous auto-immune reactivity to polyclonal Ig molecules. In one of the two patients studied, who progressed from MGUS to MM, disease progression was accompanied by an increase in this anti-Ig reactivity. In both patients there was a decrease in CD4/CD8 ratio.This publication has 39 references indexed in Scilit:
- Antibody Response to Pneumococcal Vaccination in Patients with MyelomatosisScandinavian Journal of Haematology, 2009
- Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patientsJournal of Clinical Immunology, 1988
- Analysis of immunodeficiency in multiple myeloma: Observations and hypothesisJournal of Clinical Laboratory Analysis, 1987
- Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels.JCI Insight, 1985
- T Cells in Monoclonal GammopathiesScandinavian Journal of Haematology, 1982
- Subpopulations of T-Lymphocytes in Multiple MyelomaScandinavian Journal of Haematology, 1981
- Suppression of polyclonal immunoglobulins in multiple myeloma: Relationship to the staging and other manifestations at diagnosisClinical Immunology and Immunopathology, 1980
- Serum anti-immunoglobulins in multiple myeloma and benign monoclonal gammopathyClinical Immunology and Immunopathology, 1975
- DEVELOPMENT OF A SECOND MONOCLONAL IMMUNOGLOBULIN G IN A PATIENT WITH LATE MANIFESTATION OF MYELOMAActa Medica Scandinavica, 1972
- Immunological Deficiency Disorders Associated with Chronic Lymphocytic Leukemia and Multiple Myeloma*JCI Insight, 1964